Member Exclusive

LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment

This open access special report, brought to MedChemNet users by our sister journal Future Medicinal Chemistry, provides an introduction to the first-in-class oncolytic peptide termed LTX-315.

Go to the profile of RxNet
Sep 06, 2017

Please sign in or register for FREE

No comments yet.